RepliCel Life Sciences Inc. to receive $4.2 million upfront fee, with additional royalties of $31.5 million from licensing Agreement allowing Shisedo to use RepliCel’s RCH-01 hair regeneration technology treating pattern baldness in Japan, China, South Korea, Taiwan and the ASEAN countries.
(PRWeb July 11, 2013)
Read the full story at http://www.prweb.com/releases/2013/7/prweb10916664.htm
